On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.

Contact Us

In addition to assembling a diversified team with expertise in each area of branding, investor relations, public relations and social media, we have developed a network of brands and partners to best serve both public and private companies. By engaging any one of our services, you will benefit from decades of experience accumulated by helping more than 250 companies achieve greater success.

Contact Us

Your Name *

Your Email *

Subject

Message:

Get Your Copy of The StocksToBuyNow Newsletter

You’re just a click and email verification away from joining hundreds of other subscribers receiving weekly trading ideas!

From Our Blog

CNS Pharmaceuticals Inc. (NASDAQ: CNSP) is “One to Watch”

September 25, 2020

CNS Pharmaceuticals’ lead drug candidate, Berubicin, is proposed for the treatment of glioblastoma multiforme (“GBM”), an aggressive and currently incurable form of brain cancer. In a Phase I clinical trial of Berubicin in malignant brain tumors, 44% of patients experienced a statistically significant improvement in clinical benefit. In preclinical studies, the company’s second drug candidate, […]

Rotate your device 90° to view site.